JP2001521744A5 - - Google Patents

Info

Publication number

JP2001521744A5

JP2001521744A5 JP2000519086A JP2000519086A JP2001521744A5 JP 2001521744 A5 JP2001521744 A5 JP 2001521744A5 JP 2000519086 A JP2000519086 A JP 2000519086A JP 2000519086 A JP2000519086 A JP 2000519086A JP 2001521744 A5 JP2001521744 A5 JP 2001521744A5

Authority

JP

Japan

Prior art keywords

seq

polynucleotide

fragments

specific

group

Prior art date

1998-10-19

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108091033319 polynucleotide Proteins 0.000 claims 20
• 102000040430 polynucleotide Human genes 0.000 claims 20
• 239000002157 polynucleotide Substances 0.000 claims 20
• 239000012634 fragment Substances 0.000 claims 17
• 238000000034 method Methods 0.000 claims 14
• 239000000427 antigen Substances 0.000 claims 10
• 102000036639 antigens Human genes 0.000 claims 10
• 108091007433 antigens Proteins 0.000 claims 10
• 108091034117 Oligonucleotide Proteins 0.000 claims 8
• 229920001184 polypeptide Polymers 0.000 claims 8
• 102000004196 processed proteins & peptides Human genes 0.000 claims 8
• 108090000765 processed proteins & peptides Proteins 0.000 claims 8
• 125000003275 alpha amino acid group Chemical group 0.000 claims 7
• 239000007795 chemical reaction product Substances 0.000 claims 6
• 238000004519 manufacturing process Methods 0.000 claims 6
• 208000030270 breast disease Diseases 0.000 claims 5
• 150000007523 nucleic acids Chemical class 0.000 claims 5
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 4
• 108091093088 Amplicon Proteins 0.000 claims 3
• 230000000295 complement effect Effects 0.000 claims 3
• 108700026244 Open Reading Frames Proteins 0.000 claims 2
• 150000001413 amino acids Chemical class 0.000 claims 2
• 230000000692 anti-sense effect Effects 0.000 claims 2
• 239000002299 complementary DNA Substances 0.000 claims 2
• 238000001514 detection method Methods 0.000 claims 2
• 230000002163 immunogen Effects 0.000 claims 2
• 238000003259 recombinant expression Methods 0.000 claims 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
• 101710098119 Chaperonin GroEL 2 Proteins 0.000 claims 1
• 230000015572 biosynthetic process Effects 0.000 claims 1
• 239000013604 expression vector Substances 0.000 claims 1
• 230000028993 immune response Effects 0.000 claims 1
• 108020004999 messenger RNA Proteins 0.000 claims 1
• 102000039446 nucleic acids Human genes 0.000 claims 1
• 108020004707 nucleic acids Proteins 0.000 claims 1
• 239000013612 plasmid Substances 0.000 claims 1
• 238000010839 reverse transcription Methods 0.000 claims 1